Literature DB >> 14678581

Glaucomatous optic neuropathy: when glia misbehave.

Arthur H Neufeld1, Bin Liu.   

Abstract

The loss of vision in the human eye disease, glaucoma, is due to degeneration of the axons of the retinal ganglion cells. In glaucoma, reactive astrocytes in the optic nerve head contain inducible nitric oxide synthase, which apparently produces excessive nitric oxide that damages the axons. The astrocytes respond to the elevated intraocular pressure that is characteristic of the disease. An important signal transduction pathway for the induction of nitric oxide synthase in response to pressure is the epidermal growth factor receptor tyrosine kinase. Pharmacological inhibition of the activity or the induction of inducible nitric oxide synthase may provide neuroprotection for the treatment of glaucoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678581     DOI: 10.1177/1073858403253460

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  52 in total

Review 1.  [Characteristic features of optic nerve ganglion cells and approaches for neuroprotection. From intracellular to capillary processes and therapeutic considerations].

Authors:  R H W Funk; K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

2.  Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Authors:  Wei Wang; Ann Chan; Yu Qin; Jacky M K Kwong; Joseph Caprioli; Ralph Levinson; Ling Chen; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2015-08-13       Impact factor: 3.467

Review 3.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

4.  Curcumin attenuates staurosporine-mediated death of retinal ganglion cells.

Authors:  Balabharathi Burugula; Bhagyalaxmi S Ganesh; Shravan K Chintala
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-16       Impact factor: 4.799

Review 5.  [Functional disorders in the chronological progression of glaucoma].

Authors:  Carl Erb
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

6.  Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.

Authors:  Hao Sun; William H Swanson; Brian Arvidson; Mitchell W Dul
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

7.  The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells.

Authors:  Lei Gu; Jacky M K Kwong; Daniel Yadegari; Fei Yu; Joseph Caprioli; Natik Piri
Journal:  Neurosci Lett       Date:  2018-02-02       Impact factor: 3.046

8.  Morphology of astrocytes in a glaucomatous optic nerve.

Authors:  Ming Lye-Barthel; Daniel Sun; Tatjana C Jakobs
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

9.  High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.

Authors:  Michael G Anderson; Richard T Libby; Douglas B Gould; Richard S Smith; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-09       Impact factor: 11.205

10.  New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.

Authors:  Rebecca Robinson; James P Bertram; Jill L Reiter; Erin B Lavik
Journal:  J Microencapsul       Date:  2010-05       Impact factor: 3.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.